Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.


Third Quarter 2017 Financial Results

Genmab published its Third Quarter 2017 financial results and held an investor conference call on November 8. Click here to listen to the archived webcast. Click here to download the results. Click here to download the slide presentation. Click here to download an MP3 file of the call.

Download Library

Access Genmab's financial reports, webcasts, presentations and more from the Download Library

Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore our current vacancies, learn about our culture and meet some of our team members.